# Sagimet Biosciences (SGMT) — Earnings

SGMT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/sgmt/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.32 |
| EPS estimate | −$0.51 |
| EPS surprise | +37.05% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 13, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1400118/000155837025011301/sgmt-20250630x10q.htm) |

Sagimet Biosciences reported Q2 2025 results on August 13, 2025, the most recent quarter in the table. It posted a loss of $0.32 per share, narrower than the expected $0.51 loss, a beat of 37.05%. No revenue was reported. Compared with Q2 2024, the loss per share widened from $0.25.

The record here is short, covering five quarters from Q2 2024 to Q2 2025, and every one was a loss. The loss widened from $0.25 in Q2 2024 to $0.45 in Q3 2024 and $0.50 in Q4 2024, reached $0.56 in Q1 2025, then narrowed to $0.32 in Q2 2025. Sagimet beat the EPS estimate in four of the five quarters; the only miss was Q3 2024, at 15.95% below. With no revenue in any quarter shown, the table tracks only the size of the loss per share.

The table has no report after August 2025. Past dates put the Q1 report in May, Q2 reports in mid-August, the Q3 2024 report on November 14, 2024 and the Q4 2024 report on March 12, 2025. Once newer quarters are added, they will show whether the narrower loss of Q2 2025 carried on.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 13, 2025 | −$0.51 | −$0.32 | 37.05% | — | — |
| Q1 2025 | May 8, 2025 | −$0.67 | −$0.56 | 15.90% | — | — |
| Q4 2024 | Mar 12, 2025 | −$0.62 | −$0.50 | 19.52% | — | — |
| Q3 2024 | Nov 14, 2024 | −$0.39 | −$0.45 | -15.95% | — | — |
| Q2 2024 | Aug 14, 2024 | −$0.33 | −$0.25 | 24.63% | — | — |

## Frequently Asked Questions

### When did Sagimet Biosciences (SGMT) last report earnings?

Sagimet Biosciences last reported on Aug 13, 2025, covering fiscal Q2 2025.

### Did SGMT beat earnings estimates?

Yes. Sagimet Biosciences reported EPS of −$0.32 for Q2 2025 against a −$0.51 estimate — a 37.05% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).